Envestnet Portfolio Solutions Inc. Lowers Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Envestnet Portfolio Solutions Inc. lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 16.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,924 shares of the medical device company's stock after selling 5,412 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in Cooper Companies were worth $2,271,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in COO. Ieq Capital LLC increased its position in shares of Cooper Companies by 8.7% during the fourth quarter. Ieq Capital LLC now owns 27,497 shares of the medical device company's stock valued at $2,528,000 after acquiring an additional 2,190 shares in the last quarter. ING Groep NV bought a new position in Cooper Companies during the 4th quarter valued at about $555,000. Navellier & Associates Inc. grew its stake in shares of Cooper Companies by 30.5% in the fourth quarter. Navellier & Associates Inc. now owns 4,168 shares of the medical device company's stock worth $383,000 after acquiring an additional 975 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its holdings in shares of Cooper Companies by 44.3% during the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 38,120 shares of the medical device company's stock valued at $3,504,000 after purchasing an additional 11,700 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in Cooper Companies in the fourth quarter worth approximately $1,985,000. Institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

COO has been the topic of a number of research reports. UBS Group upgraded Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. JPMorgan Chase & Co. restated a "neutral" rating and set a $76.00 price target (down from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research note on Tuesday, June 17th. Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price for the company in a research report on Tuesday, June 17th. Finally, BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $99.70.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $69.47 on Monday. The stock has a market cap of $13.89 billion, a price-to-earnings ratio of 33.72, a price-to-earnings-growth ratio of 1.69 and a beta of 0.98. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The stock has a 50 day moving average price of $77.28 and a 200-day moving average price of $84.93. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. During the same period in the previous year, the company earned $0.85 EPS. The firm's revenue for the quarter was up 6.3% compared to the same quarter last year. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.